University of Pennsylvania

ScholarlyCommons
Departmental Papers (Dental)

Penn Dental Medicine

3-2014

Application of Stem Cells Derived From the Periodontal Ligament
or Gingival Tissue Sources for Tendon Tissue Regeneration
Alireza Moshaverinia
Xingtian Xu
Chider Chen
Sahar Ansari
Homayoun H. Zadeh

See next page for additional authors

Follow this and additional works at: https://repository.upenn.edu/dental_papers
Part of the Dentistry Commons

Recommended Citation
Moshaverinia, A., Xu, X., Chen, C., Ansari, S., Zadeh, H. H., Snead, M. L., & Shi, S. (2014). Application of
Stem Cells Derived From the Periodontal Ligament or Gingival Tissue Sources for Tendon Tissue
Regeneration. Biomaterials, 35 (9), 2642-2650. http://dx.doi.org/10.1016/j.biomaterials.2013.12.053

At the time of publication, author Songtao Shi was affiliated with the University of Southern California. Currently, he
is a faculty member at the School of Dental Medicine at the University of Pennsylvania
This paper is posted at ScholarlyCommons. https://repository.upenn.edu/dental_papers/167
For more information, please contact repository@pobox.upenn.edu.

Application of Stem Cells Derived From the Periodontal Ligament or Gingival
Tissue Sources for Tendon Tissue Regeneration
Abstract
Tendon injuries are often associated with significant dysfunction and disability due to tendinous tissue’s
very limited self-repair capacity and propensity for scar formation. Dental-derived mesenchymal stem
cells (MSCs) in combination with appropriate scaffold material present an alternative therapeutic option
for tendon repair/regeneration that may be advantageous compared to other current treatment
modalities. The MSC delivery vehicle is the principal determinant for successful implementation of MSCmediated regenerative therapies. In the current study, a co-delivery system based on TGF-β3-loaded RGDcoupled alginate microspheres was developed for encapsulating periodontal ligament stem cells
(PDLSCs) or gingival mesenchymal stem cells (GMSCs). The capacity of encapsulated dental MSCs to
differentiate into tendon tissue was investigated in vitro and in vivo. Encapsulated dental-derived MSCs
were transplanted subcutaneously into immunocompromised mice. Our results revealed that after 4
weeks of differentiation in vitro, PDLSCs and GMSCs as well as the positive control human bone marrow
mesenchymal stem cells (hBMMSCs) exhibited high levels of mRNA expression for gene markers related
to tendon regeneration (Scx, DCn, Tnmd, and Bgy) via qPCR measurement. In a corresponding in vivo
animal model, ectopic neo-tendon regeneration was observed in subcutaneous transplanted MSCalginate constructs, as confirmed by histological and immunohistochemical staining for protein markers
specific for tendons. Interestingly, in our quantitative PCR and in vivo histomorphometric analyses,
PDLSCs showed significantly greater capacity for tendon regeneration than GMSCs or hBMMSCs (P
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Tendon injuries are often associated with significant dysfunction and disability due to tendinous
tissue’s very limited self-repair capacity and propensity for scar formation. Dental-derived
mesenchymal stem cells (MSCs) in combination with appropriate scaffold material present an
alternative therapeutic option for tendon repair/regeneration that may be advantageous compared
to other current treatment modalities. The MSC delivery vehicle is the principal determinant for
successful implementation of MSC-mediated regenerative therapies. In the current study, a codelivery system based on TGF-β3-loaded RGD-coupled alginate microspheres was developed for
encapsulating periodontal ligament stem cells (PDLSCs) or gingival mesenchymal stem cells
(GMSCs). The capacity of encapsulated dental MSCs to differentiate into tendon tissue was
investigated in vitro and in vivo. Encapsulated dental-derived MSCs were transplanted
subcutaneously into immunocompromised mice. Our results revealed that after 4 weeks of
differentiation in vitro, PDLSCs and GMSCs as well as the positive control human bone marrow
mesenchymal stem cells (hBMMSCs) exhibited high levels of mRNA expression for gene markers
related to tendon regeneration (Scx, DCn, Tnmd, and Bgy) via qPCR measurement. In a
corresponding in vivo animal model, ectopic neo-tendon regeneration was observed in
subcutaneous transplanted MSC-alginate constructs, as confirmed by histological and
immunohistochemical staining for protein markers specific for tendons. Interestingly, in our
quantitative PCR and in vivo histomorphometric analyses, PDLSCs showed significantly greater
capacity for tendon regeneration than GMSCs or hBMMSCs (P<0.05). Altogether, these findings
indicate that periodontal ligament and gingival tissues can be considered as suitable stem cell
sources for tendon engineering. PDLSCs and GMSCs encapsulated in TGF-β3-loaded RGDmodified alginate microspheres are promising candidates for tendon regeneration.
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1. Introduction
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Tendons are specialized tissues that connect bone to muscle, transmitting the forces
generated by these structures to allow for body movement [1]. Tendons are frequently
injured during sports and other rigorous physical activities. These injuries are often very
difficult to manage because tendons heal through fibrotic scar formation rather than a
regenerative process, leading to the formation of poor-quality tissue with low mechanical
strength [1–3]. As a result, tendon injuries can lead to long-term pain, discomfort, and
disability for patients. This limited self-repair capacity necessitates the development of
alternative therapeutic strategies to functionally repair injured tendons [3–5]. In comparison
to currently available treatment modalities, research indicates that the application of
mesenchymal stem cells (MSCs) may present an advantageous alternative therapeutic option
for the regeneration and repair of tendon tissue [6]. MSCs are pluripotent cells that can
differentiate into multiple lineages, depending on the nature of the environmental signals
they receive. Specifically with regards to their capacity to form tendon, studies have shown
that direct implantation of MSCs functionally improves tendon defects [6–8]. However,
identifying an optimal cell source is one of the crucial factors in tendon regeneration and
repair, since not all MSCs have equal capacity to form tendons. Tendon stem/progenitor
cells (TSPCs), which possess both self-renewal and multilineage differentiation capacity,
have been identified and extracted from human and mouse tendons [9]. Several studies have
proposed the application of this type of progenitor cell for tendon regeneration [8,9]. In
addition, other types of stem cells have been proposed for tendon tissue engineering,
including human bone marrow mesenchymal stem cells (hBMMSCs) and skin fibroblasts
[10, 11].
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It is well known that MSCs are found in a wide range of post-natal tissue types, including
the dental and craniofacial tissues [12–15]. Among the dental-derived MSCs, periodontal
ligament stem cells (PDLSCs) and gingival mesenchymal stem cells (GMSCs) are of
particular interest as they are accessible through the oral cavity and can be harvested easily;
indeed, they can often be obtained as discarded biological samples in dental clinics [13–16].
Furthermore, both in vitro and in vivo studies have confirmed the multilineage
differentiation capabilities of these dental-derived stem cells [13–16]. Additionally, since the
periodontal ligament is composed of tendon-like collagen bundles that are capable of
bearing occlusal forces, PDLSCs show unique potential as a source of MSCs for tendon
regenerative treatments [17].
In order to induce the differentiation of MSCs into a specific and desired lineage/phenotype,
it is necessary to deliver an appropriate and specific signal. It has been reported that stem
cell-mediated tissue regeneration is partially controlled by the recipient local
microenvironment, including the presence of growth factors, immune cells and cytokines
[18–21]. For this reason, exogenous growth factors have been delivered along with stem
cells to achieve a desired differentiation route. Here we focus on the potential of the
transforming growth factor-beta (TGF-β) signaling pathway to drive differentiation into
tendon. Studies have reported that the TGF-β pathway plays an important role in tendon
regeneration [22,23]. In addition, it has been shown that disruption of TGF-β signaling
pathway results in the loss of most tendons and ligaments. Moreover, TGFβ signaling is a
potent inducer of Scleraxis (Scx), a basic helix-loop-helix (bHLH) transcription factor gene
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that is a unique marker for the tendon cell fate in vitro and in vivo, demonstrating a vital role
for the TGF-β signaling pathway in tendon repair and regeneration [23–25]. Among the
members of the TGF-β superfamily, TGF-β3 is of particular interest as it is an isoform that
has been associated with promoting dermal wound and tendon healing without fibrotic scar
formation [26,27]. Other studies have confirmed that differentiation of MSCs driven by
TGF-β3 can promote tendon tissue formation and may provide a promising modality of
treatment for tendon regeneration and repair [24–27].
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In order to develop a promising microenvironment for tendon regeneration based on dentalderived MSCs, we sought to engineer a microenvironment with the physiochemical
characteristics of the extracellular micro-milieu. We utilized alginate hydrogel coupled with
RGD (arginine- glycine-aspartic acid tripeptide) in order to modify the niche properties and
to direct the cell phenotype through differentiation [28–30]. Hydrogel biomaterials like the
one we selected have been widely used for tissue engineering. Alginates are natural heteropolysaccharides isolated from brown sea algae that possess unique properties including
injectability and biodegradability [28–32]. Moreover, alginates can provide a 3D scaffold
that facilitates the spatial distribution of MSCs, thus resulting in a structural organization
that resembles the native in vivo microenvironment. Alginate microspheres have been used
extensively for controlled delivery of growth factors (e.g., TGF-β) and have an excellent
track record of safety [33, 35]. Also, it is has been reported that presence of cell-binding
peptides, such as RGD, in the structure of the alginate scaffold could be advantageous
because these peptides mimic the cell-matrix interaction typical of the ECM [31–33].
Recently, our research group reported that that RGD-coupled alginate hydrogel can be used
to encapsulate PDLSCs and GMSCs for cartilage regeneration via in vitro and in vivo
analyses [34]. However, a literature search revealed no reports assessing the application of
PDLSCs or GMSCs encapsulated in RGD-coupled alginate microspheres, loaded with TGFβ3, in tendon regeneration. Therefore, in the present study, we developed a co-delivery
system that provides a 3D architecture of RGD-coupled alginate hydrogel loaded with TGFβ3 ligands for the encapsulation of dental MSCs (PDLSCs and GMSCs). It was
hypothesized that the tendon regeneration capacity of PDLSCs and GMSCs encapsulated in
RGD coupled alginate microspheres, loaded with TGF-β3, making this a promising
combination for tendon tissue engineering applications. Considering the fact that GMSCs
and are easily harvested from the oral cavity and can often be obtained as discarded
biological samples, these MSC sources can be considered ideal for stem cell banking
purposes provided they show promise in MSC-based tissue regeneration. This approach was
designed to optimize tendon regeneration for potential application in the repair of the
appendicular skeleton.
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2. Materials and methods
2.1. Progenitor cell isolation and culture
Human PDLSCs and GMSCs were isolated and cultured according to previously published
procedures [15,16]. The gingival tissues and teeth were obtained from twenty healthy male
patients (18–25 years old) undergoing third molar extractions with IRB approval from the
University of Southern California. Only subjects without any history of periodontal disease
were included in this study.
2.2. Biomaterial fabrication and cell encapsulation
In this study, RGD-coupled alginate (NovaMatrix FMC Biopolymer, Norway) was used as
the scaffold material. The alginate was purified and partially oxidized (2%) to increase its
degradability according to published methods in the literature [28–30]. Subsequently, the
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alginate was concentrated, freeze-dried under reduced pressure, and mixed with TGF-β3
(Invitrogen, Carlsbad, CA) (50 μg/mL).
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PDLSCs, GMSCs, and hBMMSCs (as a positive control) were encapsulated separately in
alginate loaded with TGF-β3 ligand. Cells were encapsulated at a density of 2×106 cells/mL
of alginate solution. Microsphere formation was accomplished by adding the MSC-alginate
mixture dropwise to 100 mM CaCl2 solution. The resulting microspheres were incubated at
37°C for 45 min to complete cross-linking and then washed three times in nonsupplemented DMEM. RGD-coupled alginate hydrogel without cells (and not loaded with
TGF- β3) was used as the negative control in this study.
2.3. Live/dead staining
Following 14 days of incubation in culture medium, the cell viability of the encapsulated
MSCs was measured as described previously [28, 29] using calcein AM to stain live cells
and ethidium bromide homodimer-1 to stain dead cells (Invitrogen). The percentage of live
cells was measured using NIH ImageJ software (NIH, Bethesda, MD). The effect of the
presence of RGD tripeptide on the viability of the encapsulated MSCs was also evaluated by
encapsulating dental-derived MSCs or hBMMSCs in alginate microspheres without RGD
and performing a live/dead staining assay after 14 days of culturing.
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2.4. Scanning electron microscopy (SEM)
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2.6. In vitro release profile characterization

The morphology and structure of the microspheres were characterized using scanning
electron microscopy (SEM) (JEOL 5300, Peabody, MA). On day 14 of culture in regular
medium, the MSC-alginate microspheres were rinsed with 2 ml of PBS and fixed with 1%
glutaraldehyde overnight. Samples were dehydrated using graded alcohol solution, sputter
coated with gold, and observed using SEM.
2.5. Confocal laser scanning microscopy (CLSM)
The MSC-alginate microspheres were further characterized using CLSM (Fluoview FV10i,
Olympus Corp, Tokyo, Japan). On day 14 of culturing, encapsulated cells were fixed in
paraformaldehyde (4% in PBS) for 30 min, washed with PBS (pH = 7.4), and incubated in
0.1% Triton X-100 for 5 min at room temperature. MSCs were stained with anti-human
CD146-FITC conjugated and anti-human CD105- PE conjugated antibodies (Abcam) as
positive MSC markers. Additionally, specimens were stained with anti-CD34 PE conjugated
antibody (Santa Cruz Biotechnology Inc, Santa Cruz, CA) as a negative hematopoietic stem
cell marker. All the specimens were counterstained with DAPI for nucleus staining.

In order to characterize the release profile of TGF-β3, RGD-coupled alginate microspheres
were loaded with TGF-β3 at three different concentrations (10, 50, and 100 μg/mL) and
incubated in 500 μL of high-glucose DMEM supplemented with 100 U/mL penicillin and
100 μg/mL streptomycin in 48-well plates on a rotational shaker at 37°C for one week. At
each selected time interval (1, 3, 5, 7, 10, 12, and 14 days), the medium was collected and
analyzed for released TGF- β3 using a TGF-β3 ELISA Kit (R&D Systems Inc. Minneapolis,
MN). At the end of release study, the remaining TGF-β3 was extracted from the
microspheres by dissolving the alginate scaffolds in 50 mM sodium citrate dehydrate
solution (Sigma Aldrich, St Louis, MO) in distilled water and the percentage of cumulative
released TGF-β3 was measured. Finally, the percentage of released TGF-β3 was measured
based on the ratio of the amount released after two weeks to the amount that was initially
loaded [49].
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2.7. In vitro culture and immunofluorescence staining
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To induce tenogenic differentiation, encapsulated PDLSCs and GMSCs as well as
hBMMSCs (2×106 cells in 1 mL of TGF-β3-loaded alginate microspheres) were cultured in
a tenogenic medium containing DMEM with 15% FBS, 2 mM L-glutamine, 100 nM Dex,
100 3M ascorbic acid, 2 mM sodium pyruvate (R&D Systems Inc), 100 U/mL penicillin,
and 100 μg/mL streptomycin [26]. Cell-free RGD-coupled alginate microspheres without
TGF-β3 were used as the negative control.
Four weeks after induction, the samples were fixed with 4% PFA, and paraffin sections were
made. Sections were immunolabeled using antibodies against Tenomodulin (Tnmd), Eya 1,
Eya2 (from Santa Cruz Biotechnology, Inc, Dallas, TX), and Scleraxis (Abcam) at 4°C
overnight, detected using Alexa fluor conjugated secondary antibody (1:200 dilution;
Invitrogen), and counterstained with DAPI.
2.8. RNA isolation, reverse transcription and real time PCR
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RNA was extracted from the encapsulated cells after 2 weeks of culturing following
published methods [21]. Briefly, 10 alginate microspheres were collected and dissolved by
gentle stirring in a sterile depolymerization buffer consisting of 50 mM sodium citrate
dehydrate and 80 mM sodium chloride (Sigma Aldrich) for 15–20 min. Following
dissolution, the decapsulated cells were centrifuged at 9400 g for 10 min and the pellet was
washed with PBS and centrifuged again at 9400 g for 3 min. Total RNA was extracted using
Trizol reagent (Invitrogen) according to the manufacturer’s recommendations. Singlestranded cDNA synthesis was performed with 100 ng total RNA using a Superscript III
cDNA synthesis kit (Invitrogen). Data were analyzed by the 2-ΔΔCt method, with
normalization to the Ct of the housekeeping gene GAPDH (glyceraldehyde 3-phosphate
dehydrogenase). Primer and probe sequences are described in Table 1.
2.9. Western blot analysis
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After four weeks in culture, the differentiation of stem cells was analyzed using Western
blot analysis. Briefly, stem cell-alginate constructs were dissolved in citrate buffer (6% w/v,
pH 7.4). Cell pellets were obtained by centrifugation, washed twice with PBS, and lysed
with protein extraction buffer (Bio-Rad, Irvine, CA) for 30 sec. The supernatant was cleared
by centrifugation and the protein concentration was determined using a BCA assay (Pierce,
Rockford, IL) by extrapolation to a known BSA standard concentration by serial dilution
across one order of magnitude. Equal amounts of protein extracts were fractionated to size
by electroporation in 10% sodium dodecyl sulfate-polyacrylamide gels (PAGE), and the
size-resolved proteins were electrophoretically transferred to a nitrocellulose membrane
(Bio-Rad). The nitrocellulose membrane was incubated with rabbit antibody directed against
Tenomodulin (Tnmd) (Santa Cruz Biotechnology, Inc). Immune-protein complexes were
detected using a secondary antibody at 1:500 (polyclonal goat anti-rabbit IgG/HRP, EMD
Millipore, Billerica, MA). The membranes were stripped and re-probed with an antibody
directed against the housekeeping gene β-actin (Abcam) to ensure that equal mass was
loaded to each lane. The chemiluminescent reagent (Amersham Life Science, Pittsburgh,
PA) was added to the membrane for 1 min and exposed to x-ray film for variable periods
(Thermo Scientific, Rockford, IL) to produce images.
2.10. Tendon tissue regeneration in animal model
All animals in our in vivo experiments were treated according to the Guidelines and
Regulations for the Use and Care of Animals at the University of Southern California.
PDLSCs, GMSCs, and hBMMSCs (approximately 4 × 106 cells) were encapsulated in
alginate microspheres loaded with TGF-β3 and 10 microspheres (500 μl) were transplanted
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subcutaneously into the dorsal surface of 5-month-old Beige nude XID III (NU/NU) mice
(Harlan, Livermore, CA; N=4 for each group). After 8 weeks the mice were sacrificed, and
the microspheres and the surrounding tissue were surgically removed and analyzed using
histological and immunohistochemical staining. Cell-free RGD-coupled alginate
microspheres without TGF-β3 were used as the negative control group.
2.11. Histological and immunohistochemical analyses
For histological examination, harvested specimens were fixed in 10% formalin solution,
dehydrated in an ascending series of ethanol, and embedded in paraffin. Six-micrometer
sections were cut using a microtome and mounted on glass slides. Four randomly selected
cross-sections from each implant were stained with Hematoxylin & Eosin (H&E) and
Masson’s Trichrome. Furthermore, histological sections were observed under a polarized
light microscope to evaluate collagen fiber formation.
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For immunohistochemical analysis, de-paraffinized sections were washed, and non-specific
endogenous peroxidase activity was quenched by immersing in 3% H2O2/methanol for 15
min. Sections were incubated with primary antibody (1:200–1:300 dilution) for 1 h.
Immunohistochemistry examination was performed on sections using anti-Tenomodulin
(Santa Cruz Biotechnology, Inc, 1:100 dilution), anti-Eya 1, anti-Eya2 (Santa Cruz
Biotechnology, Inc, 1:100 dilution), anti- Scleraxis (Abcam, 1:100 dilution), and
counterstaining with hematoxylin.
The effect of RGD tripeptide on the tendon regeneration capacity of encapsulated MSCs was
also evaluated by comparison with MSCs encapsulated in non-RGD containing alginate
microspheres. Microspheres were transplanted as described above and histomorphometric
analysis was performed on slides stained with Masson’s Trichrome staining. The positive
staining was determined for 4 independent samples for each experimental group. Five areas
were randomly selected from each sample, and then the positive area in each field was
calculated with NIH Image-J software and shown as a percentage of the total field area.
2.12. Statistical Analysis
The Kruskal–Wallis rank sum test was utilized to analyze the data at a significance level of
α = 0.05. Also, a two-tailed Student’s t-test was utilized for pairwise comparisons whenever
needed. Quantitative data are expressed as mean ± standard deviation (SD).

3. Results
3.1. Biomaterial fabrication and characterization
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In this study, an RGD-coupled alginate encapsulation system was developed in order to
investigate the capacity of PDLSCs and GMCSs to contribute to tendon tissue
differentiation and regeneration. We utilized hBMMSCs encapsulated in alginate
microspheres as the positive control, whereas our negative control consisted of alginate
microspheres alone. In addition, the ability of RGD-containing alginate to contribute to
MSC viability and differentiation was examined. Alginate microspheres with an average
diameter of 1 ± 0.1 mm were fabricated. Microscopic images of the stem cell-loaded
microcapsules showed that the microcapsules were of uniform size and exhibited even cell
distribution (Fig. 1a). Live/dead assays confirmed that all the encapsulated MSC types had
high viability in culture for up to two weeks (Fig. 1b). No significant difference was
observed between the percentages of live cells in the PDLSC, GMSC and hBMMSC groups
(P>0.05). In addition, cell viability remained high well after the initial two-week culturing
period (data not shown). Furthermore, in comparison to MSCs encapsulated in non-RGD
coupled alginate microspheres, MSCs encapsulated in RGD-containing alginate
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microspheres showed significantly higher degrees of viability at all the tested time intervals
(Fig. 1b). Additionally, the effects of presence of TGF- β3 on the viability of encapsulated
MSCs were analyzed. Our data showed that the presence of RGD tripeptide played an
important role in promoting MSC viability, while the presence of TGF-β3 ligands did not
exhibit any significant effects on MSC viability (Supplementary Fig. 1S).
SEM analysis showed that the prepared scaffolds had a porous morphology and confirmed
the presence of the encapsulated MSCs (Fig. 1c). Further characterization of encapsulated
dental-derived MSCs using CLSM demonstrated that the cells expressed the specific MSC
markers CD146 and CD105, but not the hematopoietic lineage marker CD34, after two
weeks of culturing. These results confirmed the suitability of RGD-coupled alginate as the
encapsulating biomaterial for PDLSCs and GMSCs, as well as hBMMSCs (Fig. 1d).
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In the next step, alginate microspheres with three different concentrations of TGF-β3 (10, 50
and 100 μg/mL) were prepared and the release profile of TGF-β3 from the RGD-coupled
alginate scaffold was characterized for two weeks. Higher initial concentrations of TGF-β3
were observed to produce a faster release profile (Fig. 1e). The cumulative release profile
confirmed the sustained release of TGF-β3 for up to 14 days. Additionally, the effect of
initial concentration of TGF-β3 on the percentage of released ligand was evaluated and our
data (not shown) confirmed that 50 μg/mL TGF-β3 exhibited the most favorable release
profile. Therefore, this concentration was selected for the rest of the experiments in this
study.
3.2. Tenogenic differentiation of dental MSCs in vitro
After four weeks of tenogenic differentiation in vitro, tenogenic differentiation of PDLSCs,
GMSCs, and hBMMSCs was confirmed by positive immunostaining with antibodies against
Tenomodulin, Eya1, Eya2, and Scleraxis (Fig. 2). Tenomodulin (Tnmd) is a type II
transmembrane glycoprotein that is predominantly expressed in tissues such as tendons and
ligaments [36]. It has been shown that early Scleraxis-expressing progenitor cells lead to the
eventual formation of tendon tissue [36]. Additionally, Eya1 and Eya 2 genes are expressed
during limb tendon development and encode a transcriptional activation function. [47] These
transcription factors are involved in a number of cellular and developmental processes
including the development of tendons and ligaments [38].
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Next, the molecular mechanism underlying the tendon regeneration in the TGF-β3-loaded
alginate microspheres was analyzed. Gene expression analyses were performed using
several markers that are associated with tendon differentiation, including a transcription
factor Scleraxis (Scx), an extracellular matrix protein Decorin (Dcn), and a surface marker
Tenomodulin (Tnmd) [36–39], as well as Biglycan (Bgy), which is a class I small leucinerich proteoglycan (SLRP) involved in the regulation of collagen fibrillogenesis [48]. The
expression levels of these genes were confirmed and compared via RT-PCR. The results
showed that all of the MSC groups expressed abundant Scx, DCn, Tnmd, and Bgy (Figs. 3ad). However, PDLSCs showed significantly higher expression levels for all the tested genes
than GMSCs or hBMMSCs (p<0.05). No significant differences in the expression levels of
Scx, DCn, Tnmd, or Bgy were found between hBMMSCs and GMSCs (P>0.05). However,
for all the tested genes, hBMMSCs showed higher levels of expression than GMSCs did. As
expected, MSCs encapsulated in RGD-coupled alginate microspheres exhibited significantly
higher levels of tendon-specific gene expression than did their non-RGD coupled
counterparts (P<0.05) (Figs. 3a-d). In addition, further analysis clearly confirmed that TGFβ3 plays a more important role than RGD tripeptide in the tenogenic differentiation of
MSCs. Moreover, the expression levels of Dcn and Tnmd were evaluated in hBMMSCs,
PDLSCs, and GMSCs without the scaffold after two weeks of tenogenic differentiation in
vitro in the presence of TGF-β3 ligand. Interestingly, the same trend reported for the
Biomaterials. Author manuscript; available in PMC 2015 March 01.
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encapsulated MSCs (Figs. 3a-d) was observed for scaffold-free specimens (Supplementary
Fig. S2). However, in comparison to MSCs without scaffolds, the encapsulated MSCs
expressed higher levels (p>0.05) of expression for the tendon markers that were examined,
confirming the important role of the encapsulation biomaterial (Supplementary Fig. S2).
The results of Western blot analysis correlated well with the data from the immunostaining
and PCR analyses. Increased expression levels of the tenogenic-specific molecule, Tnmd,
were detected in specimens encapsulated in TGF-β3-loaded RGD-containing alginate
microspheres (Fig. 3e). In contrast, MSCs encapsulated in alginate microspheres without
RGD but still loaded with TGF-β3 exhibited very modest levels of Tnmd expression, while
encapsulated specimens in the absence of TGF-β3 and RGD failed to express Tnmd (Fig.
3f). PDLSCs encapsulated in TGF-β3-loaded RGD-containing alginate microspheres
showed higher levels of Tnmd expression than either hBMMSCs or GMSCs.
3.3. Ectopic tendon regeneration in vivo
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The ability of PDLSCs and GMSCs encapsulated in RGD-coupled alginate microspheres
loaded with TGF-β3 to regenerate tendon tissue was evaluated in an ectopic site after
subcutaneous transplantation into immunocompromised mice. Histological sections stained
with H&E and Masson’s Trichrome dyes revealed the presence of wave-like aligned fibrils
with tendon-like structure. However, a more organized structure, with more extracellular
matrix and collagen, was observed with PDLSCs in comparison to GMSCs and hBMMSCs
(Fig. 4a). Trichrome staining further confirmed the presence and regeneration of tendon-like
tissue in the experimental and positive control groups after 8 weeks of transplantation, but
no histological evidence for regeneration was observed in the negative control, cell-free
transplant group. In addition, to evaluate the deposition level of collagen, histological
sections were observed under polarized light microscopy (Fig.4b). Collagen fibers with a
yellow color were more easily observed in the PDLSC group than in the hBMMSC and
GMSC groups. Our histomorphometric analysis confirmed that MSCs encapsulated in RGDcontaining alginate microspheres exhibited significantly higher amounts of tendon tissue
regeneration (by Masson’s Trichrome staining) than their counterparts without RGD (Fig.
4c).

NIH-PA Author Manuscript

To further characterize dental-derived MSC-mediated tendon regeneration in vivo,
immunohistochemical detection was utilized to detect proteins suggested by the gene
expression analysis. Immunohistochemical staining for Scleraxis, Tenomodulin, EYA 1, and
EYA2 antigens after 8 weeks of transplantation revealed extensive production and
deposition of these markers within the regenerated tendon tissues (Fig. 5a). As expected, the
amount of tendon-like tissue generated was more pronounced in the PDLSC group than in
the GMSC or hBMMSC groups (P<0.05) (Fig. 5b), while GMSCs and hBMMSCs showed
the same moderate potential for tendon regeneration (P<0.05), as confirmed by
immunohistochemical detection of Scx protein. A considerably higher percentage of cells
were positive for anti-Scx antibody staining in the PDLSC group than in the GMSC or
hBMMSC groups (Fig. 5b). In addition, the human origin of the newly-formed tendon tissue
was confirmed via immunohistochemical staining (Fig. 5a). No evidence of cells positive for
anti-Scx antibody was observed in the cell-free RGD-coupled alginate negative control
group.

4. Discussion
Tendon injuries due to age-related degeneration or rigorous physical activity are a common
clinical problem. Damaged tendon tissue heals very slowly and rarely attains the structural
integrity or mechanical strength of normal, undamaged tendon [36]. A limited understanding
of basic tendon biology has hampered the development of new treatment options for injured
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tendons [40, 41]. Local delivery of growth factors in combination with MSCs shows
promise as a modality of treatment for tendon regeneration. Several animal studies have
confirmed that the application of MSCs can lead to significant improvement in tendon repair
and regeneration [42, 43]. Due to the tendon-like structure of collagen bundles in the
periodontal ligament, we hypothesized that PDLSCs could provide a uniquely well-suited
source of MSCs for tendon regeneration. Moreover, GMSCs, and to some extent PDLSCs,
are easily harvested from the oral cavity or can often be obtained from discarded biological
samples. Therefore, these MSC sources can be considered ideal for stem cell banking
purposes provided they show promise in MSC-based tissue regeneration. However, to our
knowledge, the capacity of PDLSCs and GMSCs to regenerate tendon tissue has previously
not been reported. Therefore, in this study alginate microspheres were coupled with the
RGD tripeptide and loaded with TGF-β3 in a strategy to optimize the microenvironment for
dental-derived MSCs to differentiate into tendon tissue while also assessing the capacity of
stem cells from the periodontal ligament and the gingiva, when encapsulated in these
alginate microspheres, to participate in tendon regeneration.
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Through our in vitro and in vivo studies, we provide evidence that our encapsulation system
supported the viability of MSCs and their differentiation into tendon-like tissue. We also
confirmed the important role of the microenvironment on the viability of encapsulated
MSCs. Additionally, in the current study we utilized two unique, easily accessible and
abundant sources of dental-derived MSCs (PDLSCs and GMSCs) for this purpose, and
showed them to be promising candidate sources for tendon tissue regeneration. From a
practical perspective, PDLSCs and GMSCs are superior sources of stem cells in comparison
to hBMMSCs, considering their accessibility and suitability for autologous transplantation.
As a result, human PDLSC- or GMSC-mediated tissue regeneration shows promise as a cellbased treatment for tendon tissue engineering. Dental-derived MSCs encapsulated in
alginate microspheres in the presence of a suitable signaling molecule (in this study, TGFβ3) could effectively induce patterns of gene expression suitable to regenerate tendon-like
tissue.
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In the current study, we found that MSCs derived from the periodontal ligament have
significantly higher levels of tendon markers mRNA expression than do hBMMSCs. Stem
cells derived from gingival tissues showed expression levels of tendon-specific markers
comparable to the levels seen in hBMMSCs. In addition, in our in vivo study, histological
analysis of regenerated tissues confirmed the formation of tendon-like organization with
typical characteristics of tendon tissue, including sinusoidal wave-like patterning of the
nuclei and cytoplasm of the cells. We confirmed our hypothesis that PDLSCs would show
greater capacity for regenerating tendon tissue than either GMSCs or hBMMSCs.
Interestingly, GMSCs showed tendon regeneration capacity comparable to that of
hBMMSCs. However, both PDLSCs and GMSCs have a unique advantage over hBMMSCs,
namely, their ready availability and high capacity for tenogenesis, which stand in marked
contrast to the more involved harvesting and osteoegenic proclivity of hBMMSCs. This
tendency toward osteogenesis is a major concern because the generation of bony tissue is an
outcome which could result in serious adverse effects for clinical tendon regenerative
applications. In contrast, no osteogenic differentiation was observed at the transplantation
sites of PDLSCs and GMSCs, as confirmed by H&E and Trichrome staining. Additionally,
in vivo culture of PDLSCs and GMSCs in the presence of TGF-β3 induction medium
showed no increase in the expression level of osteogenic markers such as OCN and ALP, as
evaluated by qPCR (data not shown), while an almost three-fold increase was observed in
the expression levels of Scx, Dcn, Tnmd, and Bgy.
It has been shown that the cell delivery vehicle plays a critical role in the effectiveness of
MSC-based regenerative therapies [44–46]. In this study, we utilized RGD-coupled alginate
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microspheres as a delivery vehicle for dental-derived MSCs. This encapsulation system
provides a unique 3D cell delivery scaffold for tendon tissue engineering. As SEM analysis
showed, the alginate microspheres exhibit a porous structure, which enables the diffusion of
oxygen, nutrients and signaling molecules throughout the alginate hydrogel. This structural
characteristic also enables growth factors, such as TGF-β3, to penetrate the alginate
microspheres and participate in regulating the proliferation and differentiation of the
encapsulated MSCs. This unique structural property, combined with the presence of RGD
tripeptide, is designed to facilitate MSC-alginate interactions, leading to enhanced MSC
adhesion and availability of oxygen, nutrients and desirable growth factors. These properties
make alginate hydrogel a highly suitable scaffold biomaterial for tendon tissue engineering.
One particularly promising aspect of the current study is the fact that the MSCs were not
required to be cultured in tendon tissue induction media prior to their participation in in vivo
studies or subcutaneous transplantation. We showed that providing a favorable
microenvironment and an initiating signal from TGF-β3 can be sufficient to promote tendon
tissue formation. The results of the current study confirmed the importance of the delivery of
appropriate cytokines, specifically TGF-β3, to support tendon tissue regeneration by the
encapsulated dental-derived MSCs. These results highlight the vital role played by the
microenvironment, as well as the value of presenting inductive signals necessary to support
the viability and differentiation of MSCs along a desired phenotype.

NIH-PA Author Manuscript

Here, we sought to establish dental-derived MSCs as a population of MSCs that can be used
in applications where the regeneration of tendon tissue is desired. Therefore, one of our
primary objectives was to determine the plasticity of these MSCs in this regenerative mode
at an ectopic site. In our future work, the combination of these dental-derived MSCs and our
RGD-coupled alginate encapsulation system will be used in sites where tendon tissue
regeneration is likely to find clinical applications.

5. Conclusions
In the current study, we developed an alternative treatment modality for tendon regeneration
based on encapsulated dental-derived stem cells, namely PDLSCs and GMSCs, using an
injectable and biodegradable RGD-coupled alginate hydrogel scaffold to support their
differentiation. The MSC and alginate constructs were shown to effectively differentiate and
organize their extracellular matrix into tendon tissue. Our findings demonstrate the
important role of the microenvironment as well as the presentation of inductive signals
(TGF-β3) for the viability and differentiation of dental MSCs into tendon-like tissue.
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Figure 1. Development and characterization of MSC encapsulation system based on TGF-β3loaded RGD coupled-alginate hydrogel

NIH-PA Author Manuscript

(a) Bright field image of translucent alginate microspheres showing their spherical shape
with a uniform cell distribution (average microsphere diameter 1 ± 0.1 mm). (b) Viability of
the encapsulated MSCs measured as a percentage of live cells in either RGD-coupled
alginate or non-RGD- coupled alginate microspheres after two weeks of culturing in regular
media. (c) SEM image of MSCs encapsulated within alginate microspheres showing the
porous morphology of the alginate hydrogel and the presence of stem cells after two weeks
of culturing in regular media. (d) Expression of stem cell surface marker CD 146 (green)
and CD 105 (red) by periodontal ligament stem cells (PDLSCs), gingival mesenchymal stem
cells (GMSCs), and human bone marrow mesenchymal stem cells (hBMMSCs) as
determined by confocal laser scanning microcopy (CLSM) analysis. CLSM images
confirmed that neither of the experimental groups (PDLSCs and GMSCs) nor the negative
control (hBMMSCs) expressed the negative hematopoietic lineage marker CD 34. (e)
Sustained release of TGF-β3 from the alginate microspheres. Characterization of the in vitro
release profile of TGF-β3-loaded alginate microspheres showing sustained release of TGFβ3. Cumulative release is calculated from the total amount of TGF-β3 released after 14 days.
Faster TGF-β3 release was observed at higher initial concentrations. *P <0.05.
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Figure 2. Tenogenic differentiation of dental MSCs in vitro

Immunofluorescence staining against Tenomodulin (Tnmd), Eya 1, Eya2, and Scleraxis
(Scx) antibodies after four weeks of tenogenic differentiation in vitro. Top panel: Tnmd: the
inserts show MSCs positioned inside alginate microspheres at higher magnification (40x)
positively immunostained with antibodies against Tenomodulin; Two middle panels: Eya1
and Eya2, respectively; Lower panel: Scx. Results confirmed that PDLSCs and GMSCs
were positively stained for tendon markers (white arrows), while the negative control (-)
unseeded alginate microsphere, without TGF-β3, immunostaining failed to show any of
these markers.
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Figure 3. Specific gene expression and underlying molecular pathway for tendon regeneration in
vitro

Expression level (in fold changes) of (a) Scx, (b) Dcn, (c) Tnmd, and (d) Bgy genes for each
encapsulated stem cell population after 4 weeks of culturing in induction media in vitro
evaluated by RT-PCR. Data were normalized by the Ct of the housekeeping gene GAPDH
and expressed relative to the expression level for the same gene at day 1. (e) Western blot
analysis showing changes in the levels of expression of regulators of tenogenesis of MSCs.
The level of Tnmd is elevated in the encapsulated MSCs in RGD-containing alginate
microspheres in the presence of TGF-β3. MSCs encapsulated in non-RGD-coupled alginate
microspheres in the presence of TGF-β3 exhibited very modest levels of Tnmd expression,
while specimens in the absence of TGF-β3, encapsulated in non-RGD-coupled alginate
microspheres failed to express Tnmd. *P <0.05, NS= not significant.
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Figure 4. Characterization of the fate of encapsulated MSCs after transplantation
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Tendon tissue formation in TGF-β3-loaded alginate microspheres was evaluated after
subcutaneous transplantation into immunocompromised mice. MSC-alginate transplants
were removed after 8 weeks, sectioned, and stained with (a) hematoxylin and eosine and
Masson’s Trichrome. The negative control (−) was an unseeded alginate scaffold.
Histological evaluation confirmed partial regeneration with typical tendon sinusoidal
morphology (indicated by asterisk). (b) Polarized light microscopy images of specimens
where C indicates collagen fibrils and A indicates unresorbed alginate scaffold. (c) The
percentage of positive stained area (by Masson’s Trichrome staining) for MSCs
encapsulated in RGD-coupled alginate microspheres is shown in comparison to non-RGDcoupled counterparts. *P <0.05, NS: not significant.
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Figure 5. Immunohistochemical characterization of the fate of encapsulated MSCs and
quantitative evaluation of in vivo tendon regeneration capacity of encapsulated MSCs

(a) Immunohistochemical staining using antibodies against Tenomodulin (Tnmd), Eya 1,
Eya2, and Scleraxis (Scx) confirmed the regeneration capacity of encapsulated MSCs.
Positive staining appears brown (black arrows) for anti-Tnmd, EYA2, and Scx antibody
staining, while negative control (−), cell free RGD coupled alginates without TGF-β3,
immunohistochemical staining results failed to identify the antigen. (b) Semi-quantitative
analysis of the percentage of MSCs positive for anti-Scx antibodies via
immunohistochemical staining images in 6a. *P <0.05, NS: not significant.
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Table 1

Oligonucleotide primers used in RT-PCR analysis.
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Gene

Sequence

Amplication (bp)

Scleraxis (Scx)

5’-AACACGGCCTTCACTGCGCTG-3’ (forward)
5’-CAGTAGCACGTTGCCCAGGTG-3’(reverse)

123

Decorin (Dcn)

5’-ATGATTGTCATAGAACTGGGC-3’ (forward)
5’-TTGTTGTTATGAAGGTAGAC-3’ (reverse)

382

Biglycan (Bgn)

5’-CTCAACTACCTGCGCATCTCAG (forward)
5’-GATGGCCTGGATTTTGTTGTG (reverse)

105

Tenomodulin (Tnmd)

5’-CCATGCTGGATGAGAGAGGTTAC-3’ (forward)
5’-CACAGACCCTGCGGCAGTA-3’ (reverse)

72

Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)

Sense: 5’-AGCCGCATCTTCTTTTGCGTC-3’:
Antisense: 5’-TCATATTTGGCAGGTTTTT CT-3’

418
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